M&A

Novo Holdings Portfolio Company ReViral to be Acquired by Pfizer

Novo Holdings A/S

COVID-19 Antiviral

Model Medicines' Oral Anti-COVID-19 Drug Candidate MDL-001 Found to Significantly Reduce Viral Load in Lungs; Accepted into NIH's Antiviral Program for Pandemics (APP)

Model Medicines

COVID-19 Research

MU Study Identifies Mutations Specific to Omicron Variant

University of Missouri

BioMed X Institute Launches Rapid Antiviral Response Platform to Prevent Future Pandemics

BioMed X